Cardium Therapeutics announced that it has entered into a distribution agreement with AvKARE Inc. to become the new sales and distribution partner for Excellagen(R) in government medical facilities throughout the United States. This new agreement and commercialization arrangement with AvKARE effectively replaces an earlier arrangement with Academy Medical, LLC. Cardium elected to transfer the Excellagen distribution responsibilities to AvKARE, which provides five direct wound care experts and allows Cardium's 25 distributor representatives access to all government accounts.

AvKARE services a diverse customer base that includes government (federal, state and municipal) and commercial sectors.